Skip to main content

Table 1 Comparison of the general situation of the two groups of patients

From: Study on the effectiveness and safety of ciprofol in anesthesia in gynecological day surgery: a randomized double-blind controlled study

 

Ciprofol group

(n = 64)

Propofol group

(n = 64)

P-value

Age,year,mean ± SDs

42.2 ± 9.46

44.1 ± 9.4

0.21

Weight,Kg,mean ± SDs

58.7 ± 6.1

59.8 ± 6.9

0.37

Height,cm,mean ± SDs

160.6 ± 4.4

160.2 ± 4.9

0.62

BMI,Kg/m2,mean ± SDs

22.8 ± 2.2

23.3 ± 2.6

0.21

ASA status,n(%)

I

18(28.1)

14(21.9)

0.41

II

46(71.9)

50(78.1)

 

Operation type,n(%)

Uteroscope

48(75.0)

54(84.4)

 

Conization of cervix

16(25.0)

9(14.1)

0.18

other

0(0.0)

1(1.6)

 

Venipuncture site,n(%)

Back of the hand

46(71.9)

33(51.6)

 

Wrist

15(23.4)

22(34.4)

0.059

Forearm

0(0)

1(1.6)

 

Elbow

3(4.7)

8(12.5)

 

Induced dose,mg,mean ± SDs

29.4 ± 3.0

119.5 ± 13.9

 

Maintenance Dose,mg,mean ± SDs

14.8 ± 9.8

85.6 ± 44.0

 

Anesthesia time,min,mean ± SDs

19.4 ± 8.2

19.9 ± 6.5

0.68